Artículos

Plasma folate and homocysteine levels may be related to interictal "schizophrenia-like" psychosis in patients with epilepsy / Akira Monji en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 3-5 Título : Plasma folate and homocysteine levels may be related to interictal "schizophrenia-like" psychosis in patients with epilepsy Tipo de documento: texto impreso Autores: Akira Monji, Autor ; Kazuyuki Yanagimoto, Autor ; Toshihiko Maekawa, Autor Fecha de publicación: 2023 Artículo en la página: pp. 3-5 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Electroencefalografía, Epilepsia, Homocisteína, Psicología esquizofrénica Resumen: Genetic and clinical data suggest that folate and homocysteine may play a role in the pathogenesis of psychiatric disorders. The total plasma homocysteine level is a sensitive measure of a functional folate deficiency. We thus investigated whether a functional folate deficiency and/or elevated levels of plasma homocysteine may be related to interictal "schizophrenia-like" psychosis (interictal psychosis ) of epilepsy. Link: ./index.php?lvl=notice_display&id=30919 [artículo] Plasma folate and homocysteine levels may be related to interictal "schizophrenia-like" psychosis in patients with epilepsy [texto impreso] / Akira Monji, Autor ; Kazuyuki Yanagimoto, Autor ; Toshihiko Maekawa, Autor . - 2023 . - pp. 3-5. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 3-5 Palabras clave: Electroencefalografía, Epilepsia, Homocisteína, Psicología esquizofrénica Resumen: Genetic and clinical data suggest that folate and homocysteine may play a role in the pathogenesis of psychiatric disorders. The total plasma homocysteine level is a sensitive measure of a functional folate deficiency. We thus investigated whether a functional folate deficiency and/or elevated levels of plasma homocysteine may be related to interictal "schizophrenia-like" psychosis (interictal psychosis ) of epilepsy. Link: ./index.php?lvl=notice_display&id=30919

Dopamine d3 receptor ser9gly polymorphism and risperidone response / Hsien Yuan Lane en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 6-11 Título : Dopamine d3 receptor ser9gly polymorphism and risperidone response Tipo de documento: texto impreso Autores: Hsien Yuan Lane, Autor ; Shih-Kuan Hsu, Autor ; Yi-Ching Liu, Autor Fecha de publicación: 2023 Artículo en la página: pp. 6-11 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, ADN - genética, Polimorfismo, Genética, Receptores de Dopamina D2, Risperidona, Esquizofrenia, Comportamiento social Resumen: Risperidone is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of schizophrenia. Risperidone is a potent dopamine D3 antagonist and agonism at D3 sites induces behavioral suppression in rodents. We thus hypothesized that D3 antagonism may contribute to response to risperidone in negative symptoms. Link: ./index.php?lvl=notice_display&id=30920 [artículo] Dopamine d3 receptor ser9gly polymorphism and risperidone response [texto impreso] / Hsien Yuan Lane, Autor ; Shih-Kuan Hsu, Autor ; Yi-Ching Liu, Autor . - 2023 . - pp. 6-11. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 6-11 Palabras clave: Antipsicóticos, ADN - genética, Polimorfismo, Genética, Receptores de Dopamina D2, Risperidona, Esquizofrenia, Comportamiento social Resumen: Risperidone is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of schizophrenia. Risperidone is a potent dopamine D3 antagonist and agonism at D3 sites induces behavioral suppression in rodents. We thus hypothesized that D3 antagonism may contribute to response to risperidone in negative symptoms. Link: ./index.php?lvl=notice_display&id=30920

Association between antipsychotic treatment and hyperlipidemia among california medicaid patients with schizophrenia / Bruce L. Lambert en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 12-18 Título : Association between antipsychotic treatment and hyperlipidemia among california medicaid patients with schizophrenia Tipo de documento: texto impreso Autores: Bruce L. Lambert, Autor ; Ken Yu Chang, Autor ; Eskinder Tafesse, Autor Fecha de publicación: 2023 Artículo en la página: pp. 12-18 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Hiperlipidemias, Agentes hipolipemiantes, Esquizofrenia. Resumen: To examine the risk of hyperlipidemia among people with schizophrenia exposed to new antipsychotics (clozapine, olanzapine, quetiapine, risperidone) compared with those exposed to older generation antipsychotics. Link: ./index.php?lvl=notice_display&id=30921 [artículo] Association between antipsychotic treatment and hyperlipidemia among california medicaid patients with schizophrenia [texto impreso] / Bruce L. Lambert, Autor ; Ken Yu Chang, Autor ; Eskinder Tafesse, Autor . - 2023 . - pp. 12-18. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 12-18 Palabras clave: Antipsicóticos, Hiperlipidemias, Agentes hipolipemiantes, Esquizofrenia. Resumen: To examine the risk of hyperlipidemia among people with schizophrenia exposed to new antipsychotics (clozapine, olanzapine, quetiapine, risperidone) compared with those exposed to older generation antipsychotics. Link: ./index.php?lvl=notice_display&id=30921

Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults / David S. Janowsky en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 19-25 Título : Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults Tipo de documento: texto impreso Autores: David S. Janowsky, Autor ; L. Jarrett Barnhill, Autor ; Mahesh Shetty, Autor Fecha de publicación: 2023 Artículo en la página: pp. 19-25 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agresión, Antipsicóticos, Discapacidad Intelectual, Comportamiento autolesivo. Resumen: Retrospective review of records from 1990 to 1997 revealed unsuccessful attempts to withdraw antipsychotic medications from a total of 34 intellectually disabled individuals. The lowest dose of antipsychotic medication necessary to maintain symptom suppression and the dose at which relapse occurred were noted. Link: ./index.php?lvl=notice_display&id=30922 [artículo] Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults [texto impreso] / David S. Janowsky, Autor ; L. Jarrett Barnhill, Autor ; Mahesh Shetty, Autor . - 2023 . - pp. 19-25. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 19-25 Palabras clave: Agresión, Antipsicóticos, Discapacidad Intelectual, Comportamiento autolesivo. Resumen: Retrospective review of records from 1990 to 1997 revealed unsuccessful attempts to withdraw antipsychotic medications from a total of 34 intellectually disabled individuals. The lowest dose of antipsychotic medication necessary to maintain symptom suppression and the dose at which relapse occurred were noted. Link: ./index.php?lvl=notice_display&id=30922

Antipsychotic drugs / Veronica O'Keane en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 26-31 Título : Antipsychotic drugs : A new risk factor for osteoporosis in young women with schizophrenia? Tipo de documento: texto impreso Autores: Veronica O'Keane, Autor ; Anna Maria Meaney, Autor Fecha de publicación: 2023 Artículo en la página: pp. 26-31 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Consumo de alcohol, Antipsicóticos, Índice de masa corporal, Enfermedades Óseas, Hiperprolactinemia, Hipogonadismo, Alteraciones de la menstruación, Osteoporosis. Resumen: Schizophrenic illness is associated with high rates of osteoporosis, the etiology of which remains obscure, but which may be at least partly explained by the prolactin-raising properties of antipsychotic medication. Conventional antipsychotics all cause hyperprolactinemia, whereas a limited number of atypical antipsychotic drugs do not. Link: ./index.php?lvl=notice_display&id=30923 [artículo] Antipsychotic drugs : A new risk factor for osteoporosis in young women with schizophrenia? [texto impreso] / Veronica O'Keane, Autor ; Anna Maria Meaney, Autor . - 2023 . - pp. 26-31. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 26-31 Palabras clave: Consumo de alcohol, Antipsicóticos, Índice de masa corporal, Enfermedades Óseas, Hiperprolactinemia, Hipogonadismo, Alteraciones de la menstruación, Osteoporosis. Resumen: Schizophrenic illness is associated with high rates of osteoporosis, the etiology of which remains obscure, but which may be at least partly explained by the prolactin-raising properties of antipsychotic medication. Conventional antipsychotics all cause hyperprolactinemia, whereas a limited number of atypical antipsychotic drugs do not. Link: ./index.php?lvl=notice_display&id=30923

Effects of additional oxazepam in long-term users of oxazepam / Richard C. Oude Voshaar en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 42-50 Título : Effects of additional oxazepam in long-term users of oxazepam Tipo de documento: texto impreso Autores: Richard C. Oude Voshaar, Autor ; Robbert Jan Verkes, Autor ; Gilles L.J.M. van Luijtelaar, Autor Fecha de publicación: 2023 Artículo en la página: pp. 42-50 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ansiolíticos, Ansiedad - terapia con medicamentos, Hipnóticos y Sedantes, Trastornos de la memoria, Recuerdo mental, Oxazepam. Resumen: Although additional dosages of benzodiazepines in long-term users of benzodiazepines are common, it is unknown whether these additional dosages resort any effect. The effects of an additional 20-mg dosage oxazepam were assessed in a double-blind, balanced-order, crossover randomized study comparing 16 long-term users of oxazepam (patients) with 18 benzodiazepine-naive controls (controls). Link: ./index.php?lvl=notice_display&id=30924 [artículo] Effects of additional oxazepam in long-term users of oxazepam [texto impreso] / Richard C. Oude Voshaar, Autor ; Robbert Jan Verkes, Autor ; Gilles L.J.M. van Luijtelaar, Autor . - 2023 . - pp. 42-50. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 42-50 Palabras clave: Ansiolíticos, Ansiedad - terapia con medicamentos, Hipnóticos y Sedantes, Trastornos de la memoria, Recuerdo mental, Oxazepam. Resumen: Although additional dosages of benzodiazepines in long-term users of benzodiazepines are common, it is unknown whether these additional dosages resort any effect. The effects of an additional 20-mg dosage oxazepam were assessed in a double-blind, balanced-order, crossover randomized study comparing 16 long-term users of oxazepam (patients) with 18 benzodiazepine-naive controls (controls). Link: ./index.php?lvl=notice_display&id=30924

St. John's wort versus placebo in social phobia / Kenneth Kobak en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 51-58 Título : St. John's wort versus placebo in social phobia : Results from a placebo-controlled pilot study Tipo de documento: texto impreso Autores: Kenneth Kobak, Autor ; Leslie v.H Taylor, Autor ; Gemma Warner, Autor Fecha de publicación: 2023 Artículo en la página: pp. 51-58 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Hipérico, Trastornos fóbicos, Fitoterapia - efectos adversos Resumen: Recognition of social anxiety disorder (social phobia) as a common and disabling condition has led to new advances in its pharmacotherapy. Limitations with selective seroton reuptake inhibitors (side effects) and behavior therapy (scarcity of trained therapists), coupled with the tendency for patients with the disorder to self-medicate with alternative treatments, have led to the interest in Saint John's wort (SJW) (Hypericum perforatum) for this disorder. Link: ./index.php?lvl=notice_display&id=30925 [artículo] St. John's wort versus placebo in social phobia : Results from a placebo-controlled pilot study [texto impreso] / Kenneth Kobak, Autor ; Leslie v.H Taylor, Autor ; Gemma Warner, Autor . - 2023 . - pp. 51-58. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 51-58 Palabras clave: Hipérico, Trastornos fóbicos, Fitoterapia - efectos adversos Resumen: Recognition of social anxiety disorder (social phobia) as a common and disabling condition has led to new advances in its pharmacotherapy. Limitations with selective seroton reuptake inhibitors (side effects) and behavior therapy (scarcity of trained therapists), coupled with the tendency for patients with the disorder to self-medicate with alternative treatments, have led to the interest in Saint John's wort (SJW) (Hypericum perforatum) for this disorder. Link: ./index.php?lvl=notice_display&id=30925

Adverse cardiac effects associated with clozapine / David A. Merrill en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 32-41 Título : Adverse cardiac effects associated with clozapine Tipo de documento: texto impreso Autores: David A. Merrill, Autor ; G. William Dec, Autor ; Donald C. Goff, Autor Fecha de publicación: 2023 Artículo en la página: pp. 32-41 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Miocardiopatías, Clozapina, Muerte - Súbita - Cardíaca, Enfermedades cardíacas, Miocarditis. Resumen: To review the published literature on serious adverse cardiac events associated with the atypical antipsychotic agent, clozapine, and to make recommendations for cardiac assessment of candidates for clozapine treatment and for monitoring of cardiac status after treatment is initiated. Link: ./index.php?lvl=notice_display&id=30926 [artículo] Adverse cardiac effects associated with clozapine [texto impreso] / David A. Merrill, Autor ; G. William Dec, Autor ; Donald C. Goff, Autor . - 2023 . - pp. 32-41. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 32-41 Palabras clave: Antipsicóticos, Miocardiopatías, Clozapina, Muerte - Súbita - Cardíaca, Enfermedades cardíacas, Miocarditis. Resumen: To review the published literature on serious adverse cardiac events associated with the atypical antipsychotic agent, clozapine, and to make recommendations for cardiac assessment of candidates for clozapine treatment and for monitoring of cardiac status after treatment is initiated. Link: ./index.php?lvl=notice_display&id=30926

The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding / Pär Hallberg en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 59-73 Título : The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding : A review and clinical aspects Tipo de documento: texto impreso Autores: Pär Hallberg, Autor ; Viktoria Sjöblom, Autor Fecha de publicación: 2023 Artículo en la página: pp. 59-73 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Lactancia materna, Intercambio materno-fetal, Atención posnatal, Embarazo, Complicaciones del embarazo, Inhibidores selectivos de la recaptación de serotonina Resumen: Mood and anxiety disorders are common in women during their childbearing years. The prevalence of depression has been reported to be between 10% and 16% during pregnancy. The use of selective serotonin reuptake inhibitors during pregnancy or lactation is, to date, not promoted because of lack of safety documentation. Link: ./index.php?lvl=notice_display&id=30927 [artículo] The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding : A review and clinical aspects [texto impreso] / Pär Hallberg, Autor ; Viktoria Sjöblom, Autor . - 2023 . - pp. 59-73. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 59-73 Palabras clave: Lactancia materna, Intercambio materno-fetal, Atención posnatal, Embarazo, Complicaciones del embarazo, Inhibidores selectivos de la recaptación de serotonina Resumen: Mood and anxiety disorders are common in women during their childbearing years. The prevalence of depression has been reported to be between 10% and 16% during pregnancy. The use of selective serotonin reuptake inhibitors during pregnancy or lactation is, to date, not promoted because of lack of safety documentation. Link: ./index.php?lvl=notice_display&id=30927